Burning Rock Biotech (BNR) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Burning Rock Biotech Limited reported a decrease in first-quarter revenue by 11.9% year-over-year due to a strategic shift towards in-hospital testing, despite the segment’s own revenue growing by 11.3%. The company saw a significant decrease in operating expenses, contributing to a reduced net loss compared to the previous year. Burning Rock also indicated a breakeven target for 2024, adjusting to a new corporate structure with its headquarters now in Guangzhou.
For further insights into BNR stock, check out TipRanks’ Stock Analysis page.